- Diagnostics
- Friday, 05 Jun 2020
Japan to have coronavirus vaccines in use by June 2021
Drugmakers around the world are scrambling to develop a treatment or vaccine for COVID-19, the respiratory disease caused by the highly infectious new coronavirus which has so far killed nearly 400,000 people worldwide.
“We will be securing production facilities in parallel with expedited vaccine development,” Japan’s Health Minister Katsunobu Kato told reporters as he outlined plans to bring vaccines into use by the end of the first half of 2021.
Usually, plants for actual vaccine production are arranged only after the successful completion of development.
The Japanese government has earmarked 146 billion yen ($1.34 billion) for vaccine production and distribution in the second extra budget that Prime Minister Shinzo Abe’s cabinet approved last month.
Japanese pharmaceutical firms developing coronavirus vaccines include Shionogi & Co and AnGes Inc.
Related Industry Updates
Quest Diagnostics Begins to Perform COVID-19 Antibody Testing
Apr 22, 2020
Cryotherapy Market Business Opportunity 2021 – Top Companies : ZIMMER MEDIZINSYSTEME GMBH,Impact Cryotherapy.,CryoConcepts LP,MEDTRONIC,METRUM CRYOFLEX Ltd & More
May 12, 2021
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 26, 2020
Natera Launches Zenith Genomics for Rare Disease in US Healthcare
Mar 13, 2026
qFIBS Demonstrates Suitability for Nonalcoholic Steatohepatitis (NASH) Assessment in Clinical Trials and Patient Care with Full Quantification of All Crucial Histopathological Features
Nov 11, 2019
Yuyu Pharma will export COVID-19 test sets from SD BIOSENSOR to the world market
Jun 18, 2020
Cosmetic Surgery: Guide to Procedures & What to Know
Mar 23, 2026
Follow us on
